Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CASI Pharmaceuticals (CASI) Net Income - Minority (2022)

Historic Net Income - Minority for Pharmaceuticals (CASI) over the last 1 years, with Q4 2022 value amounting to -$33.9 million.

  • Pharmaceuticals' Net Income - Minority changed N/A to -$33.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$33.9 million, marking a year-over-year change of. This contributed to the annual value of -$33.9 million for FY2022, which is N/A changed from last year.
  • Pharmaceuticals' Net Income - Minority amounted to -$33.9 million in Q4 2022.
  • Pharmaceuticals' 5-year Net Income - Minority high stood at -$33.9 million for Q4 2022, and its period low was -$33.9 million during Q4 2022.